Form D · Pharmaceuticals

LQ3 Pharmaceuticals, Inc.

Morrisville, NC · CIK 0001614268

Offering snapshot reported Dec 17, 2014 · SEC filing

Reported sold
$2.35M
Offering amount: $10M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 10, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.18M$2.35MJul 23, 2014: $1,999,998.00Jul 23, 2014Dec 17, 2014: $2,352,940.00Dec 17, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,999,998 → $2,352,940
  • Reported investors3 → 4

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 17, 2014Amendment$2,352,940$352,942vs Jul 23, 20144SEC filing
Jul 23, 2014Initial$1,999,998No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-221630

Source: Form D, filed Dec 17, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tim Albury Executive
Stephen Bloch Director
Kyle Chenet Director, Executive, Promoter
Neal Fowler Director
Shawn Glidden Executive
Seth Rudnick Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
419 Davis Drive Suite 100
Morrisville, NC, 27560